Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phase I studies: what to measure?

B Rosenkranz1

  • 1Clinical Research/Clinical Pharmacology, Hoechst AG Frankfurt, Germany.

Fundamental & Clinical Pharmacology
|January 1, 1990
PubMed
Summary

Phase I studies assess new drug safety and efficacy using clinical data and subjective scales. Careful selection of measurement times and validated methods is crucial for accurate pharmacodynamic assessment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Application of Caco-2 cell line in herb-drug interaction studies: current approaches and challenges.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques·2014
Same author

The pharmacokinetics of enteral antituberculosis drugs in patients requiring intensive care.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2013
Same author

Clinical pharmacology becomes a specialty in South Africa.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2013
Same author

Para-aminosalicylic acid plasma concentrations in children in comparison with adults after receiving a granular slow-release preparation.

Journal of tropical pediatrics·2012
Same author

Pharmacokinetics of isoniazid, rifampin, and pyrazinamide in children younger than two years of age with tuberculosis: evidence for implementation of revised World Health Organization recommendations.

Antimicrobial agents and chemotherapy·2011
Same author

Pharmacokinetics of ethionamide in children.

Antimicrobial agents and chemotherapy·2011

Area of Science:

  • Pharmacology
  • Clinical Trials
  • Drug Development

Background:

  • Drug development requires rigorous assessment of new compound quality, safety, and efficacy.
  • Phase I studies are critical for evaluating tolerability, pharmacodynamics, and pharmacokinetics of novel compounds.
  • Standard clinical, laboratory, and subjective measures are employed for safety assessment.

Purpose of the Study:

  • Investigate drug tolerability, pharmacodynamic effects, and pharmacokinetics in early-stage trials.
  • Determine proof of efficacy, mechanism of action, and optimal dosage in humans.
  • Identify potential adverse events and therapeutically relevant interactions.

Main Methods:

  • Utilize standard clinical parameters (e.g., blood pressure, heart rate, ECG) and laboratory data.
  • Employ subjective rating scales and questionnaires for patient-reported outcomes.
  • Incorporate additional investigations based on pharmacological and toxicological findings.

Main Results:

  • Pharmacological effects may correlate with peak serum concentration or show delayed onset.
  • Accurate measurement timing is essential for capturing maximum drug effects.
  • Validated, non-invasive methods and appropriate variables are key to reliable results.

Conclusions:

  • Standardized pharmacodynamic study procedures are necessary to predict therapeutic effects.
  • Appropriate selection of variables, methods, and time points is crucial for robust study outcomes.
  • Phase I studies provide essential data for advancing new drug candidates through development.

Related Experiment Videos